Biosimilars benefit patients, doctors and healthcare systems

Biosimilars are central to the future of affordable healthcare as they benefit for various stakeholders in healthcare systems.

Biosimilars can benefit patients through increased access to treatments.

Biosimilars can benefit doctors and healthcare professionals by offering them increased choice of treatments.
Sandoz is the generics and biosimilars division of Novartis.
For more information: https://www.sandoz.com/products-services/biopharmaceuticals

Watch the full “Biosimilars and Sandoz” video here: https://youtu.be/o91j8lB7jy4

Видео Biosimilars benefit patients, doctors and healthcare systems канала Sandoz